Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Hallberg P, Karlsson J, Lind L, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H. Hallberg P, et al. Among authors: melhus h. Clin Cardiol. 2004 May;27(5):287-90. doi: 10.1002/clc.4960270510. Clin Cardiol. 2004. PMID: 15188945 Free PMC article. Clinical Trial.
[Vitamins are not always good!].
Johansson S, Kindmark A, Michaëlsson K, Melhus H. Johansson S, et al. Among authors: melhus h. Lakartidningen. 2001 Mar 14;98(11):1252-5. Lakartidningen. 2001. PMID: 11293131 Swedish. No abstract available.
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, Nyström F, Hägg A, Lind L; Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Trial. Kurland L, et al. Among authors: melhus h. J Hypertens. 2001 Oct;19(10):1783-7. doi: 10.1097/00004872-200110000-00012. J Hypertens. 2001. PMID: 11593098 Clinical Trial.
Association between oxidative stress and bone mineral density.
Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H. Basu S, et al. Among authors: melhus h. Biochem Biophys Res Commun. 2001 Oct 19;288(1):275-9. doi: 10.1006/bbrc.2001.5747. Biochem Biophys Res Commun. 2001. PMID: 11594785
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, Nyström F, Hägg A, Lind L. Kurland L, et al. Among authors: melhus h. J Hypertens. 2002 Apr;20(4):657-63. doi: 10.1097/00004872-200204000-00023. J Hypertens. 2002. PMID: 11910301 Clinical Trial.
Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, Nyström F, Hägg A, Lind L. Kurland L, et al. Among authors: melhus h. Am J Hypertens. 2002 May;15(5):389-93. doi: 10.1016/s0895-7061(02)02256-2. Am J Hypertens. 2002. PMID: 12022239 Clinical Trial.
200 results